Genicular Nerve Phenol Neurolysis Versus Radiofrequency Ablation for Pain Relief in Grade 4 Knee Osteoarthritis
- Conditions
- Joint Pain
- Registration Number
- NCT06864390
- Lead Sponsor
- Ain Shams University
- Brief Summary
The goal of this clinical trial is to compare the efficiency and efficacy of genicular nerves blockade by chemical phenol neurolysis versus radiofrequency ablation in managing pain in patients suffering from grade IV KOA in term of NRS pain score.
The participants will be evaluated by numeric rating scale and oxford knee score for assessment of pain relief up to 16 weeks.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 114
- Grade 4 knee osteoarthritis according to Kellgren-Lawrence radiological classification.
- Failure to manage pain with conservative methods.
- Prior knee replacement
- Patients with cardiac pacemakers or implantable cardiac defibrillators.
- Septic knee or systemic sepsis.
- Allergy to any of the drugs used in the study.
- Coagulopathy or patients on anticoagulants.
- Patients with psychiatric illness.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Numeric rating scale baseline, 2, 4, 8,12 and 16 weeks after the procedure By an independent physician pain will be recorded using numeric rating scale which is a screening tool used to assess pain severity using a 0 - 10 scale with zero meaning no pain and 10 meaning the worst pain ever.
- Secondary Outcome Measures
Name Time Method oxford knee score baseline, 4, 8, 12, 16 weeks after the procedure This score is used to assess both function and pain of the knee on a scale ranging from 0 (worst pain and function) and 48 (best function and no pain) this score will be recorded by an independent physician
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.